Literature DB >> 10462544

Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme.

A R Van Rompay1, M Johansson, A Karlsson.   

Abstract

Phosphorylation of deoxycytidine analogs by cellular enzymes is a prerequisite for the activity of these compounds. We have investigated the kinetic parameters for the phosphorylation of 1-beta-D-arabinofuranosylcytosine (araC) and 2', 2'-difluorodeoxycytidine (dFdC) to their diphosphate forms catalyzed by human UMP-CMP kinase. We cloned the cDNA of this enzyme to enable characterization of the recombinant protein, determine its expression in different tissues, and determine the chromosome location of the gene. We showed that the recombinant UMP-CMP kinase phosphorylated CMP, dCMP, and UMP with highest efficiency and dUMP, AMP, and dAMP with lower efficiency. The monophosphates of araC and dFdC were shown to be phosphorylated with similar efficiency as dCMP and CMP. We further showed, in a combined enzymatic assay, that human deoxycytidine kinase and UMP-CMP kinase together phosphorylated araC, dFdC, and 2',3'-dideoxycytidine to their diphosphate forms. Northern blot analysis showed that the UMP-CMP kinase mRNA was ubiquitously present in human tissues as a 3.9-kb transcript with highest levels in pancreas, skeletal muscle, and liver. The human UMP-CMP kinase gene was localized to chromosome 1p34.1-1p33 by radiation hybrid analysis. We further expressed the UMP-CMP kinase as a fusion protein to the green fluorescent protein in Chinese hamster ovary cells, and showed that the fusion protein was located in the cytosol and nucleus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462544     DOI: 10.1124/mol.56.3.562

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulation.

Authors:  Florence Fassy; Odile Krebs; Maryse Lowinski; Paul Ferrari; Jacques Winter; Véronique Collard-Dutilleul; Khadidja Salahbey Hocini
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

2.  Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.

Authors:  Jun Wang; Gregory J S Lohman; JoAnne Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

3.  Introduction of a fluorine atom at C3 of 3-deazauridine shifts its antimetabolic activity from inhibition of CTP synthetase to inhibition of orotidylate decarboxylase, an early event in the de novo pyrimidine nucleotide biosynthesis pathway.

Authors:  Jan Balzarini; Federico Gago; Wim Kulik; André B P van Kuilenburg; Anna Karlsson; Matt A Peterson; Morris J Robins
Journal:  J Biol Chem       Date:  2012-06-24       Impact factor: 5.157

4.  Evaluation of DNA methylation and mRNA expression of heat shock proteins in thermal manipulated chicken.

Authors:  A Vinoth; T Thirunalasundari; M Shanmugam; A Uthrakumar; S Suji; U Rajkumar
Journal:  Cell Stress Chaperones       Date:  2017-08-25       Impact factor: 3.667

5.  Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells.

Authors:  Ken Ohmine; Kei Kawaguchi; Sumio Ohtsuki; Fuyuhiko Motoi; Shinichi Egawa; Michiaki Unno; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2012-03-15       Impact factor: 4.200

6.  Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: covalent modification.

Authors:  Gregory J S Lohman; Joanne Stubbe
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

7.  The Rv1712 Locus from Mycobacterium tuberculosis H37Rv codes for a functional CMP kinase that preferentially phosphorylates dCMP.

Authors:  Caroline Thum; Cristopher Z Schneider; Mario S Palma; Diógenes S Santos; Luiz A Basso
Journal:  J Bacteriol       Date:  2009-01-30       Impact factor: 3.490

8.  Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.

Authors:  Yan Liu; Kevin Marks; Glenn S Cowley; Julian Carretero; Qingsong Liu; Thomas J F Nieland; Chunxiao Xu; Travis J Cohoon; Peng Gao; Yong Zhang; Zhao Chen; Abigail B Altabef; Jeremy H Tchaicha; Xiaoxu Wang; Sung Choe; Edward M Driggers; Jianming Zhang; Sean T Bailey; Norman E Sharpless; D Neil Hayes; Nirali M Patel; Pasi A Janne; Nabeel Bardeesy; Jeffrey A Engelman; Brendan D Manning; Reuben J Shaw; John M Asara; Ralph Scully; Alec Kimmelman; Lauren A Byers; Don L Gibbons; Ignacio I Wistuba; John V Heymach; David J Kwiatkowski; William Y Kim; Andrew L Kung; Nathanael S Gray; David E Root; Lewis C Cantley; Kwok-Kin Wong
Journal:  Cancer Discov       Date:  2013-05-28       Impact factor: 39.397

9.  Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5'-diphosphate in the presence or absence of reductant.

Authors:  Erin Artin; Jun Wang; Gregory J S Lohman; Kenichi Yokoyama; Guixue Yu; Robert G Griffin; Galit Bar; JoAnne Stubbe
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

Review 10.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.